Circumsporozoite protein as a potential target for antimalarials

Expert Review of Anti-Infective Therapy

Volumn 13, Issue 8, 2015, Pages 923-926

  Fernández Arias, Cristina ^a   Mashoof, Sara ^a   Huang, Jing ^a   Tsuji, Moriya ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CIRCUMSPOROZOITE PROTEIN; MALARIA VACCINE; MONOCLONAL ANTIBODY; CIRCUMSPOROZOITE PROTEIN, PROTOZOAN; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY;

AMINO TERMINAL SEQUENCE; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; CARBOXY TERMINAL SEQUENCE; DRUG EFFECT; DRUG TARGETING; EDITORIAL; GENE TRANSFER; HUMAN; INFECTION PREVENTION; MALARIA FALCIPARUM; NONHUMAN; PARASITE TRANSMISSION; PARASITE VIRULENCE; PLASMODIUM BERGHEI INFECTION; SPOROZOITE; ANIMAL; ANTAGONISTS AND INHIBITORS; IMMUNOLOGY; MALARIA, FALCIPARUM; METABOLISM; PASSIVE IMMUNIZATION; PLASMODIUM FALCIPARUM; TRANSMISSION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIMALARIALS; HUMANS; IMMUNIZATION, PASSIVE; MALARIA VACCINES; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

EID: 84936935638     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.2015.1058709     Document Type: Editorial

References (41)

1. Yoshida N, Nussenzweig RS, Potocnjak P, et al. Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science 1980; 207(4426):71-3
2. Potocnjak P, Yoshida N, Nussenzweig RS, et al. Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection. J Exp Med 1980;151(6): 1504-13
3. Yoshida N, Potocnjak P, Nussenzweig V, et al. Biosynthesis of Pb44, the protective antigen of sporozoites of Plasmodium berghei. J Exp Med 1981;154(4):1225-36
4. Nardin EH, Nussenzweig V, Nussenzweig RS, et al. Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J Exp Med 1982;156(1):20-30
5. Godson GN, Ellis J, Svec P, et al. Identification and chemical synthesis of a tandemly repeated immunogenic region of Plasmodium knowlesi circumsporozoite protein. Nature 1983;305(5929):29-33
6. Ozaki LS, Svec P, Nussenzweig RS, et al. Structure of the plasmodium knowlesi gene coding for the circumsporozoite protein. Cell 1983;34(3):815-22
7. Enea V, Ellis J, Zavala F, et al. DNA cloning of Plasmodium falciparum circumsporozoite gene: amino acid sequence of repetitive epitope. Science 1984; 225(4662):628-30
8. Enea V, Arnot D, Schmidt EC, et al. Circumsporozoite gene of plasmodium cynomolgi (Gombak):cDNA cloning and expression of the repetitive circumsporozoite epitope. Proc Natl Acad Sci USA 1984; 81(23):7520-4
9. Arnot DE, Barnwell JW, Tam JP, et al. Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope. Science 1985;230(4727):815-18
10. Dame JB, Williams JL, McCutchan TF, et al. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science 1984; 225(4662):593-9
11. McCutchan TF, Lal AA, de la Cruz VF, et al. Sequence of the immunodominant epitope for the surface protein on sporozoites of Plasmodium vivax. Science 1985;230(4732):1381-3
12. Eichinger DJ, Arnot DE, Tam JP, et al. Circumsporozoite protein of Plasmodium berghei: gene cloning and identification of the immunodominant epitopes. Mol Cell Biol 1986;6(11):3965-72
13. Lal AA, de la Cruz VF, Welsh JA, et al. Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii. A rodent model for examining antimalarial sporozoite vaccines. J Biol Chem 1987;262(7):2937-40
14. Procell PM, Collins WE, Campbell GH. Circumsporozoite protein of the human malaria parasite Plasmodium ovale identified with monoclonal antibodies. Infect Immun 1988;56(2):376-9
15. Krettli AU, Rocha EM, Lopes JD, et al. Circumsporozoite protein of Plasmodium gallinaceum characterized by monoclonal antibodies. Parasite Immunol 1988;10(5): 523-33
16. Cochrane AH, Collins WE, Nussenzweig RS. Monoclonal antibody identifies circumsporozoite protein of Plasmodium malariae and detects a common epitope on Plasmodium brasilianum sporozoites. Infect Immun 1984;45(3):592-5
17. Hollingdale MR, Nardin EH, Tharavanij S, et al. Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies. J Immunol 1984;132(2):909-13
18. Charoenvit Y, Mellouk S, Cole C, et al. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites. J Immunol 1991;146(3):1020-5
19. Del Giudice G, Tougne C, Renia L, et al. Characterization of murine monoclonal antibodies against a repetitive synthetic peptide from the circumsporozoite protein of the human malaria parasite, Plasmodium falciparum. Mol Immunol 1991;28(9): 1003-9
20. Sina BJ, Wright C, Ballou R, et al. A protective monoclonal antibody with dual specificity for Plasmodium falciparum and Plasmodium berghei circumsporozoite proteins. Exp Parasitol 1992;74(4):431-40
21. Ak M, Bower JH, Hoffman SL, et al. Monoclonal antibodies of three different immunoglobulin G isotypes produced by immunization with a synthetic peptide or native protein protect mice against challenge with Plasmodium yoelii sporozoites. Infect Immun 1993;61(6):2493-7
22. Udhayakumar V, Qari SH, Patterson P, et al. Monoclonal antibodies to the circumsporozoite protein repeats of a Plasmodium vivax-like human malaria parasite and Plasmodium simiovale. Infect Immun 1994;62(5):2098-100
23. Chappel JA, Hollingdale MR, Kang AS. IgG(4) Pf NPNA-1 a human anti-Plasmodium falciparum sporozoite monoclonal antibody cloned from a protected individual inhibits parasite invasion of hepatocytes. Hum Antibodies 2004;13(3):91-6
24. Stuber D, Bannwarth W, Pink JR, et al. New B cell epitopes in the Plasmodium falciparum malaria circumsporozoite protein. Eur J Immunol 1990;20(4):819-24
25. Burkot TR, Da ZW, Geysen HM, et al. Fine specificities of monoclonal antibodies against the Plasmodium falciparum circumsporozoite protein: recognition of both repetitive and non-repetitive regions. Parasite Immunol 1991;13(2):161-70
26. Plassmeyer ML, Reiter K, Shimp RL Jr, et al. Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate. J Biol Chem 2009;284(39):26951-63
27. Rocha EM, Hollingdale MR, Sina B, et al. Common epitopes in the circumsporozoite proteins of Plasmodium berghei and Plasmodium gallinaceum identified by monoclonal antibodies to the P. gallinaceum circumsporozoite protein. J Eukaryot Microbiol 1993;40(1):61-3
28. Espinosa DA, Gutierrez GM, Rojas-Lopez M, et al. Proteolytic cleavage of the plasmodium falciparum circumsporozoite protein is a target of protective antibodies. J Infect Dis 2015. [Epub ahead of print]
29. Tsuji M, Corradin G, Zavala F. Monoclonal antibodies recognize a processing dependent epitope present in the mature CS protein of various plasmodial species. Parasite Immunol 1992;14(5): 457-69
30. Gonzalez-Ceron L, Rodriguez MH, Wirtz RA, et al. Plasmodium vivax: a monoclonal antibody recognizes a circumsporozoite protein precursor on the sporozoite surface. Exp Parasitol 1998;90(3): 203-11
31. de Lara Capurro M, Coleman J, Beerntsen BT, et al. Virus-expressed, recombinant single-chain antibody blocks sporozoite infection of salivary glands in Plasmodium gallinaceum-infected Aedes aegypti. Am J Trop Med Hyg 2000;62(4): 427-33
32. Isaacs AT, Jasinskiene N, Tretiakov M, et al. Transgenic Anopheles stephensi coexpressing single-chain antibodies resist Plasmodium falciparum development. Proc Natl Acad Sci USA 2012;109(28):E1922-30
33. Sumitani M, Kasashima K, Yamamoto DS, et al. Reduction of malaria transmission by transgenic mosquitoes expressing an antisporozoite antibody in their salivary glands. Insect Mol Biol 2013;22(1):41-51
34. Deal C, Balazs AB, Espinosa DA, et al. Vectored antibody gene delivery protects against Plasmodium falciparum sporozoite challenge in mice. Proc Natl Acad Sci USA 2014;111(34):12528-32
35. RTS,S Clinical Trials Partnership. Agnandji ST, Lell B, et al. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med 2012;367(24): 2284-95
36. Campo JJ, Sacarlal J, Aponte JJ, et al. Duration of vaccine efficacy against malaria: 5th year of follow-up in children vaccinated with RTS,S/AS02 in Mozambique. Vaccine 2014;32(19):2209-16
37. RTS,S Clinical Trials Partnership. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 2015. [Epub ahead of print]
38. Miura K, Jongert E, Deng B, et al. Effect of ingested human antibodies induced by RTS, S/AS01 malaria vaccination in children on Plasmodium falciparum oocyst formation and sporogony in mosquitoes. Malar J 2014;13:263
39. Foquet L, Hermsen CC, van Gemert GJ, et al. Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection. J Clin Invest 2014;124(1):140-4
40. Cohen S, McGregor IA, Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature 1961;192:733-7
41. Nussenzweig V, Nussenzweig RS. Circumsporozoite proteins of malaria parasites. Cell 1985;42(2):401-3